Today: 20 March 2026
Browse Category

NASDAQ:PSTV 26 September 2025 - 25 November 2025

PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

Plus Therapeutics’ CNSide Diagnostics signed a national agreement with UnitedHealthcare to cover its CNSide tumor cell test, effective Sept. 15, potentially reaching over 51 million members. PSTV shares surged about 60% premarket on Sept. 25 after the news. CNSide’s Houston lab secured CLIA accreditation the prior week. Plus Therapeutics also received $1.9 million in non-dilutive funding from CPRIT on Sept. 22.

Stock Market Today

  • Fundstrat's GRNI ETF Hits Unusual Volume Amid Mixed Component Performance
    March 20, 2026, 1:05 PM EDT. The Fundstrat Granny Shots US Large Cap & Income ETF (GRNI) traded over 633,000 shares Friday, far exceeding its three-month average of about 71,000. GRNI shares slipped 0.6% on the day. Major components saw varied activity: Nvidia's stock declined 1.5% on over 90 million shares, Tesla fell 1.1% with volume surpassing 34 million. Oneok led gains, rising 3.7%, while Vistra lagged, down 6.5%. The surge in ETF trading volume highlights increased investor interest amid mixed performance among key holdings.
Go toTop